Growing Geriatric Demographics Fueling Advancements In The Gastric Volvulus Treatment Market Driver: A Major Catalyst in the Evolution of the Gastric Volvulus Treatment Market in 2025

What market dynamics are playing a key role in accelerating the growth of the gastric volvulus treatment market?
The growth of the gastric volvulus treatment market is anticipated to be spurred by an increasing geriatric population. This specifically refers to individuals who are aged 65 years and over. Due to a weakened immune system and aging, this demographic often grapples with numerous diseases, including gastric volvulus which typically affects those over 50 years old. As such, market growth is likely to be driven by this aging population. As an example, the Population Reference Bureau (PRB), a nonprofit organization based in the US, published statistics in January 2024 that projected the number of Americans aged 65 and older will rise from 58 million in 2022 to 82 million in 2050, an increase of 47%. Their share in the total population is also expected to grow from 17% to 23%. Overall, the surge in the geriatric population is fueling the demand in the gastric volvulus treatment market.

Get Your Gastric Volvulus Treatment Market Report Here:
https://www.thebusinessresearchcompany.com/report/gastric-volvulus-treatment-global-market-report

How will the growth rate of the gastric volvulus treatment market shape industry trends by 2034?
In recent times, the gastric volvulus treatment market has seen significant expansion. There is expected growth from $27.36 billion in 2024 to $28.95 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.8%. The historical growth can be credited to developments in surgical procedures, enhancements in diagnostic technology, increased awareness and education, uptick in minimally invasive procedures, and extensive research and clinical trials.

In the coming years, the market for gastric volvulus treatment is predicted to experience robust growth. Anticipated to expand to $37.48 billion by 2029, with a compound annual growth rate (CAGR) of 6.7%. This surge during the forecast period is credited to regulatory modifications and approvals, innovative surgical procedures, an increasing older population, tailored treatment plans, and the use of sophisticated imaging approaches. Notable trends projected for this period include the advancement of minimally invasive surgeries, heightened awareness and preventative measures, research developments in treatment methods, cooperative medical practices, and personalized treatment strategies.

Get Your Free Sample Now - Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp

What trends are poised to drive the future success of the gastric volvulus treatment market?
One prevailing trend in the gastric volvulus treatment market is the advent of product innovations. Key market players are launching groundbreaking products to maintain their stronghold in the market. For instance, Pfizer Inc., an American pharmaceuticals giant, announced in October 2023 that the U.S. Food and Drug Administration (FDA) had given the green light to VELSIPITY (etrasimod). This product is a one-a-day oral sphingosine-1-phosphate (S1P) receptor activator intended for individuals suffering from moderate to severe active ulcerative colitis (UC). With a recommended dosage of 2mg, VELSIPITY offers adult patients a chance to achieve a steroid-free resolution through an oral pill taken daily, which boasts a beneficial risk-benefit profile. The FDA granting VELSIPITY approval signifies a significant shift for UC patients who are in need of innovative treatments and are set to begin advanced therapy for this chronic disease.

Which primary segments of the gastric volvulus treatment market are driving growth and industry transformations?
The gastric volvulus treatment market covered in this report is segmented -

1) By Type: Organo-Axial Volvulus, Mesentero-Axial Volvulus
2) By Treatment Type: Medication, Surgery
3) By Route Of Administration: Oral, Parenteral
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy
5) By End-User: Hospitals, Homecare, Specialty Clinics, Other End-Users

Subsegments:
1) By Organo-Axial Volvulus: Surgical Intervention, Endoscopic Management, Gastropexy, Other Treatment Methods
2) By Mesentero-Axial Volvulus: Surgical Intervention, Gastropexy, Endoscopic Techniques, Other Treatment Approaches

Unlock Exclusive Market Insights - Purchase Your Research Report Now!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9382

Which geographical regions are pioneering growth in the gastric volvulus treatment market?
North America was the largest region in the gastric volvulus market in 2024. Asia-Pacific is expected to be the fastest-growing region in the gastric volvulus treatment market report during the forecast period. The regions covered in the gastric volvulus treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Who are the influential players reshaping the gastric volvulus treatment market landscape?
Major companies operating in the gastric volvulus treatment market include PAI Pharma, Sun Pharmaceutical Industries Ltd., ANI Pharmaceuticals Inc., Fresenius SE and Co. KGaA, Mayne Pharma Group Limited, Sawai Pharmaceutical Co.Ltd., Teva Pharmaceutical Industries Ltd., Glenmark Pharmaceuticals Ltd., Tris Pharma Inc., Pfizer Inc., Mallinckrodt Pharmaceuticals, GlaxoSmithKline plc, Endo International plc, Vintage Labs, Zydus Group, Bayer AG, AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., UCB S.A., Novartis International AG, Merck & Co. Inc., Bristol-Myers Squibb Company, Sanofi S.A., Celltrion Inc., HanAll Biopharma, AstraZeneca plc

Customize Your Report - Get Tailored Market Insights!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9382&type=smp

What Is Covered In The Gastric Volvulus Treatment Global Market Report?

• Market Size Forecast: Examine the gastric volvulus treatment market size across key regions, countries, product categories, and applications.
• Segmentation Insights: Identify and classify subsegments within the gastric volvulus treatment market for a structured understanding.
• Key Players Overview: Analyze major players in the gastric volvulus treatment market, including their market value, share, and competitive positioning.
• Growth Trends Exploration: Assess individual growth patterns and future opportunities in the gastric volvulus treatment market.
• Segment Contributions: Evaluate how different segments drive overall growth in the gastric volvulus treatment market.
• Growth Factors: Highlight key drivers and opportunities influencing the expansion of the gastric volvulus treatment market.
• Industry Challenges: Identify potential risks and obstacles affecting the gastric volvulus treatment market.
• Competitive Landscape: Review strategic developments in the gastric volvulus treatment market, including expansions, agreements, and new product launches.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.